eNauka - pregled
Pregled prema Projekat Yuhan
Prikaz rezultata 1 do 2 od 2
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2022 | A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829)![]() | Cho, BC; ...; Zaric, Bojan | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2023 | Management of paresthesia in patients treated with lazertinib: Integrated analysis of LASER201 and LASER301 studies![]() | Lee, Y-G; ...; Zaric, B | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
